PI
MRNA icon

PEAK6 Investments’s Moderna MRNA Stock Holding History

PEAK6 Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.22M Sell
48,200
-48,100
-50% -$4.42M 0.01% 1193
2024
Q2 		$11.4M Sell
96,300
-8,800
-8% -$1.11M 0.03% 440
2024
Q1 		$11.2M Sell
105,100
-174,700
-62% -$17.6M 0.03% 474
2023
Q4 		$27.8M Buy
279,800
+36,400
+15% +$3.06M 0.1% 166
2023
Q3 		$25.1M Sell
243,400
-93,100
-28% -$10.4M 0.12% 136
2023
Q2 		$40.9M Sell
336,500
-85,300
-20% -$11.4M 0.19% 76
2023
Q1 		$64.8M Sell
421,800
-139,400
-25% -$23M 0.31% 42
2022
Q4 		$101M Buy
561,200
+55,000
+11% +$8.99M 0.58% 16
2022
Q3 		$59.9M Sell
506,200
-46,800
-8% -$7.1M 0.25% 49
2022
Q2 		$71.8M Sell
553,000
-446,400
-45% -$63.8M 0.14% 106
2022
Q1 		$172M Buy
999,400
+393,400
+65% +$66.2M 0.37% 32
2021
Q4 		$154M Sell
606,000
-667,200
-52% -$195M 0.33% 42
2021
Q3 		$490M Buy
1,273,200
+890,700
+233% +$328M 1.09% 7
2021
Q2 		$89.9M Buy
382,500
+248,400
+185% +$44.4M 0.21% 78
2021
Q1 		$17.6M Buy
134,100
+113,900
+564% +$16.5M 0.04% 397
2020
Q4 		$2.11M Buy
20,200
+15,800
+359% +$1.6M ﹤0.01% 1804
2020
Q3 		$311K Buy
+4,400
New +$307K ﹤0.01% 3201

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PEAK6 Investments's MRNA Position: Q3 2024 in Review

PEAK6 Investments reduced its Moderna (MRNA) stake by 46% in Q3 2024, selling an estimated $4M and leaving 51,611 shares worth $3.45M. The position accounts for 0.01% of the portfolio, ranked #1158.

PEAK6 Investments first reported a position in MRNA in Q4 2020 and has held it in 14 quarters since. The position peaked at $68.8M in Q4 2021. 789 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • PEAK6 Investments held 51,611 shares of Moderna worth $3.45M as of Q3 2024.
  • PEAK6 Investments sold 43,585 Moderna shares in Q3 2024, an estimated $4M.
  • Moderna made up 0.01% of PEAK6 Investments's portfolio in Q3 2024, its #1158 holding.
  • PEAK6 Investments first reported a position in Moderna in Q4 2020 and has held it in 14 quarters since.
  • PEAK6 Investments's Moderna position peaked at $68.8M in Q4 2021.
  • 789 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.